Viewing Study NCT03868007



Ignite Creation Date: 2024-05-06 @ 12:50 PM
Last Modification Date: 2024-10-26 @ 1:05 PM
Study NCT ID: NCT03868007
Status: COMPLETED
Last Update Posted: 2022-11-29
First Post: 2019-03-06

Brief Title: Protective Effects of RIC in Elderly With Acute Ischemic Stroke Complicating Acute Coronary Syndrome
Sponsor: Capital Medical University
Organization: Capital Medical University

Study Overview

Official Title: Protective Effects of Remote Ischemic Conditioning in Elderly With Acute Ischemic Stroke Complicating Acute Coronary Syndrome A Single-center Randomised Controlled Trial
Status: COMPLETED
Status Verified Date: 2022-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: RIC-ACS
Brief Summary: Remote ischemic conditioning RIC is a noninvasive strategy in which one or more cycles of brief and transient limb ischemia confers protection against prolonged and severe ischemia in distant organsThis study aimed to investigate whether RIC is safe and effective in patients with AIS complicating ACS
Detailed Description: Remote ischemic conditioning RIC is a noninvasive strategy in which one or more cycles of brief and transient limb ischemia confers protection against prolonged and severe ischemia in distant organs eg brain and heartIt has been demonstrated to be an effective strategy to reduce plasma myocardial enzyme infarct volume and incidence of post-ACS heart failure in patients with ACS Additionally recent studies have found that RIC was safe and feasible in patients with AIS even in those caused by large artery occlusion and treated with reperfusion therapy and it might benefit AIS patients by reducing the risk of brain tissue infarction and improving functional outcomes To date however it is still unknow whether RIC a systematic protective strategy could benefit patients with AIS complicating ACSThis study aimed to investigate whether RIC is safe and effective in patients with AIS complicating ACS

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None